Sigyn Therapeutics (SIGY) Inventory Average (2018 - 2024)
Sigyn Therapeutics (SIGY) posted Inventory Average of $50000.0 for Q3 2024, little changed sequentially from $50000.0 in Q2 2024, and little changed YoY from $50000.0 in Q4 2023.
Sigyn Therapeutics (SIGY) Inventory Average (2018 - 2024) Analysis & Trends
Sigyn Therapeutics has reported Inventory Average for 7 years, with the latest figure at $50000.0 in Q3 2024.
- Quarterly Inventory Average changed 0.0% year-over-year to $50000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $50000.0 (changed 0.0% YoY) and the FY2023 annual result came in at $50000.0, changed 0.0% from the prior year.
- Inventory Average held at $50000.0 in Q3 2024 per SIGY's latest filing, from $50000.0 in the prior quarter.
- Over five years, Inventory Average peaked at $587978.5 in Q1 2020 and troughed at $50000.0 in Q1 2022.
- A 5-year average of $261841.3 and a median of $50000.0 in 2022 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2023: Inventory Average plunged 91.47% in 2022, then changed 0.0% in 2023.
- Over 5 years, Inventory Average stood at $586047.0 in 2020, then sank by 45.73% to $318023.5 in 2021, then sank by 84.28% to $50000.0 in 2022, then changed by 0.0% to $50000.0 in 2023, then changed by 0.0% to $50000.0 in 2024.
- According to Business Quant data, Inventory Average over the past three periods registered $50000.0, $50000.0, and $50000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | - |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 50,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 318,023.50 |
| Sep 30, 2021 | 586,047.00 |
| Jun 30, 2021 | 586,047.00 |
| Mar 31, 2021 | 586,047.00 |
| Dec 31, 2020 | 586,047.00 |
| Sep 30, 2020 | 586,947.00 |
| Jun 30, 2020 | 587,847.00 |
| Mar 31, 2020 | 587,978.50 |
| Dec 31, 2019 | 640,075.50 |